Published at: 15th April, 2025 In a fast-evolving pharmaceutical landscape, strategic insights are no longer a luxury—they are essential. Whether you're planning a product launch, evaluating a pipeline molecule, or eyeing global markets, having accurate, evidence-backed intelligence can make all…
Recent Post
- CDSCO’s Revised Guidance on Common Submission Format for Import & Registration of Drugs: What Changed in 2026
- DPCO (Amendment) Order, 2026: Overcharging Liability Relief for Pharma manufacturers
- CDSCO Directs Ibuprofen Manufacturers to Add ‘Fixed Drug Eruption’ to PILs
- No Registration Certificate, No Entry for Imported Cosmetics
- CDSCO Clarifies Jurisdiction for Compounding of Offences Applications
